Denver, CO -- May 15, 2018 -- InvestorsHub NewsWire --
Ubiquitech Software Corp. (UBQU), through its operating subsidiary
HempLifeToday.com, is expanding its position in the multi-billion
Dollar skin care market, and entering the lucrative sports medicine
market, with two new CannazALL™ Hemp CBD products currently under
development.
The new CannazALL Hemp CBD products are a 4oz 200mg CBD Skin
Lotion, and a 2oz 150mg CBD muscle Gel. Both are uniquely infused
with essential oils, botanicals, vitamins, as well as pleasing
organic scents. These new products will be sold alongside the
Companies very popular CannazALL™ CBD Skin Salve, giving the
Company a strong position in the skin care and sports medicine CBD
market.
The New CannazALL products will feature a price point similar to
the Company’s popular Skin Salve, and the Company will also offer a
“Bundled” offer, of its new Skin Lotion, Muscle Gel, and Skin Salve
at a special price.
CEO James Ballas stated “With the addition of these new
products we are gaining yet another entre into the expanding CBD
marketplace, and this gives us additional avenues to reach more
customers. The new skin lotion and muscle gel are highly sought
after and we have great plans for these products”
COO Luke Dreyer added “We are constantly striving to create
the best business in our space and we continue to position for
growth. We believe that we are very close to a huge growth period
as we have taken the time to create a large footprint in the
industry, and to build a first class reputation as well. It takes
time to develop what we have and we are very close to seeing the
results of our efforts”
These new CannazALL™ CBD products will be available on the
HempLifeToday.com Website by June 30th and the Company will be
announcing additional products in the coming weeks.
James Ballas adds “Everything we do is based on our desire
to grow the Company in a manner that ensures smooth operations and
compliance with our industry. As Luke mentioned, we absolutely
believe we are close to the rapid growth we have been pursuing and
that is great for our customers, the Company, and our
shareholders”
HempLife Today™ is expecting to continue to capitalize on the
surging Cannabis market that many are projecting to reach 18
billion per year by 2021. With a strong percentage of this
contributed to hemp based products the Company expects to continue
its growth by offering quality CannazALL™ hemp derived CBD, and
full spectrum hemp products, to the public.
The Company has initiated additional shareholders services and
many shareholders have already reached out to Craig Fischer for
corporate updates. The company intends to update on additional new
product offerings throughout the summer, and will also have news on
its new division called CryptoBuy™ in the near future.
About Ubiquitech Software Corp
Ubiquitech Software Corp, through its subsidiaries is a dynamic
multi-media, multi-faceted corporation utilizing state-of-the-art
global internet marketing, DirectResponse (DRTV) Television, Radio,
Internet Content, and traditional marketing to drive traffic to the
new and emerging multi-billion dollar industries like its
subsidiaries HempLifeToday™ and CryptoBuy.com
About HempLife Today™
HempLifeToday™ focuses on the exciting and dynamic new thinking
in the world today that recognizes the important health and life
enriching enhancement that CBD Oil from the Hemp plant can bring.
Through its network of quality USA growers HempLifeToday.com™ has
developed multiple and proprietary CannazALL™ CBD oil products that
include; It’s popular CBD Tinctures, Concentrated Oils, GelCaps,
Skin Salve, e-liquid, and CannazALL Pets™ CBD products all offered
@ www.HempLifeToday.com
About CryptoBuy
CryptoBuy.com focuses on the burgeoning new world of Crypto
Currencies and is created to be a service to persons interested in
tracking and trading the many existing and future Crypto Currencies
worldwide.
This press release contains forward-looking statements. Words
such as "expects", "intends'', "believes'', and similar expressions
reflecting something other than historical fact are intended to
identify forward-looking statements, but are not the exclusive
means of identifying such statements. These forward-looking
statements involve a number of risks and uncertainties, including
the timely development and market acceptance of products and
technologies, the ability to secure additional sources of finance,
the ability to reduce operating expenses, and other factors
described in the Company's filings with the OTC Markets Group. The
actual results that the Company achieves may differ materially from
any forward-looking statement due to such risks and uncertainties.
The Company undertakes no obligation to revise or update any
forward- looking statements in order to reflect events or
circumstances that may arise after the after the date of this
release.